718. Activity of Ceftolozane–Tazobactam and Ceftazidime–Avibactam Against Clinical P. aeruginosa Isolates Collected in United States and Canada—SMART 2018

BACKGROUND: Ceftolozane–tazobactam (C/T) is an antipseudomonal cephalosporin combined with a β-lactamase inhibitor. The combination was cleared by FDA and EMA and is approved in the United States and over 60 countries worldwide. Using clinical isolates collected in the United States and Canada as pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Lob, Sibylle, Kazmierczak, Krystyna, Raddatz, Janet, DePestel, Daryl, Young, Katherine, Motyl, Mary, Sahm, Daniel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811128/
http://dx.doi.org/10.1093/ofid/ofz360.786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811128/
http://dx.doi.org/10.1093/ofid/ofz360.786

Ejemplares similares